ClinConnect ClinConnect Logo
Search / Trial NCT06185686

Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients

Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Dec 14, 2023

Trial Information

Current as of July 26, 2025

Recruiting

Keywords

Proton Therapy Radiation Brain Tumor

ClinConnect Summary

This clinical trial is looking at how radiation therapy, which is a common treatment for brain tumors in children and young adults, affects the brain's ability to function, particularly in areas responsible for thinking and memory. Researchers want to understand how changes in brain networks after treatment might lead to difficulties in thinking and learning, which can impact a patient’s ability to live independently. By using advanced imaging techniques, the study aims to identify specific changes in the brain based on the amount of radiation received.

To participate in this study, individuals need to be between 8 and 21 years old and have a newly diagnosed primary brain tumor that will be treated with a type of radiation called proton therapy. They also need to be able to understand the study and agree to participate, with help from a parent or guardian if required. Participants will undergo brain imaging before and after their treatment to help researchers gather important information about how radiation impacts brain function. This study is currently recruiting participants, and taking part could help improve understanding of cognitive challenges faced by young brain tumor survivors.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Between 8 and 21 years of age, inclusive
  • Newly diagnosed primary brain tumor of any location and any histology that will be treated with proton radiation therapy
  • Life expectancy of at least one year
  • Able to understand and willing to consent or assent to the research proposed (or that of a legally authorized representative, if applicable), along with consent of legal guardian(s) if applicable
  • Exclusion Criteria:
  • Presence of visual impairment to an extent that the patient is unable to complete the computer testing
  • Contraindication to MRI scan (i.e. due to cardiac pacemaker)
  • Presence of programmable shunt or dental braces
  • Requires sedation for MRI scans

About Washington University School Of Medicine

Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.

Locations

Saint Louis, Missouri, United States

Patients applied

0 patients applied

Trial Officials

Stephanie Perkins, M.D.

Principal Investigator

Washington University School of Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported